Germany
Japan
United Kingdom
China
Antibodies
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5E3
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Lipoteichoic Acid (LTA) mouse monoclonal antibody, clone 55, Low Endotoxin
| Applications | ELISA, IF, IHC, WB |
Candida albicans rabbit polyclonal antibody, Purified
| Applications | ELISA, ID, Ie, IF, IHC |
| Reactivities | Candida |
| Immunogen | Candida albicans, type A (ATTCC #32354). |
Biotin Conjugated Goat Anti-Rabbit IgG
| Applications | WB: 1:200-400; ICC: 1:100-200; IHC: 1:100-200; ELISA: 1:5,000-20,000 |
| Reactivities | Rabbit IgG |
| Conjugation | Biotin |
| Immunogen | Rabbit IgG, whole molecule |
Rabbit Polyclonal Antibody against GFAP (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This GFAP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 10-40 amino acids from the N-terminal region of human GFAP. |
USD 745.00
5 Days
ACTH (POMC) (1-24) mouse monoclonal antibody, clone 57 (BGN/1388/66), Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Human, Rat |
beta 2 Microglobulin (B2M) rabbit polyclonal antibody, HRP
| Applications | ELISA, EM, IHC, WB |
| Reactivities | Human |
| Conjugation | HRP |
| Immunogen | Beta-2-Microglobulin [Human Urine]. |
pan Dengue Virus mouse monoclonal antibody, clone Dengue 1-11(3), Purified
| Applications | ELISA, IF, IHC, WB |
S1PR2 rabbit polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Synthetic peptide, corresponding to amino acids 281-330 of Human EDG-5. |
Vsx2 (N-term) sheep polyclonal antibody, Purified
| Applications | IHC, WB |
| Reactivities | Mouse, Rat |
| Immunogen | A recombinant protein corresponding to amino acids 1 to 131 derived from the N-terminal of the Human Chx10 protein conjugated to GST. |
Rabbit Anti-Mouse IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Mouse IgG |
| Conjugation | Unconjugated |
| Immunogen | Mouse IgG, whole molecule |
GFAP chicken polyclonal antibody, Aff - Purified
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Recombinant Human GFAP (expressed in bacteria). After repeated injections, immune eggs were collected, the IgY fractions were purified from the yolks. |
USD 230.00
2 Weeks
Hantavirus (Puumala Nucleocapsid) mouse monoclonal antibody, clone A1C5, Supernatant
| Applications | IF, IHC, WB |
Collagen II (COL2A1) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Bovine, Human, Mouse, Rat, Sheep |
| Immunogen | Collagen type II purified from Human knee and Bovine nasal cartilage. |
Pdpn hamster monoclonal antibody, clone 811, Purified
| Applications | IHC, IP, WB |
| Reactivities | Mouse |
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
USD 220.00
2 Weeks
p75 NGF Receptor (NGFR) (1-160) mouse monoclonal antibody, clone NGFR5, Purified
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Feline, Ferret, Human, Monkey, Rabbit |
C1QA mouse monoclonal antibody, clone JL-1, Biotin
| Applications | ELISA, FN, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
Lyve1 rabbit polyclonal antibody, Purified
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse, Rat |
| Immunogen | Highly pure recombinant Mouse soluble LYVE-1 (Ala24-Gly228) produced in insect cells (Cat.-No DA3524). This recombinant soluble LYVE-1 consists of amino acid 24 (Ala) to 228 (Gly) and is fused to a C-terminal His-tag (6xHis). |
ABCC4 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human ABCC4 |
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
USD 420.00
In Stock
USD 680.00
2 Weeks
Human IgG1 (Fc specific) mouse monoclonal antibody, clone NI 132 (HP 6186), Biotin
| Applications | To identify the presence of IgG1 in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, immunoperoxidase staining of cytoplasmic IgG1, and Immunoblotting. As a second step an avidin or streptavidin conjugate of the customer's choice have to be used. General Recommended Dilutions: Immunocytochemistry. Immunohistochemistry (Paraffin). Histochemical Use: 1/10-1/40. ELISA: 1/100-1/2000. Western blot: 1/200-1/4000. |
| Reactivities | Human |
| Conjugation | Biotin |
Cd80 hamster monoclonal antibody, clone 16-10A1, Aff - Purified
| Applications | FC, FN, IHC, IP |
| Reactivities | Canine, Mouse |
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Desmoglein 2 (DSG2) mouse monoclonal antibody, clone 10G11, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
USD 340.00
2 Weeks
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone KS19.2(Z105.6), Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Amphibian, Bovine, Chicken, Human, Rat |
p21 (CDKN1A) mouse monoclonal antibody, clone WA-1, Purified
| Applications | FC, IF, IHC |
| Reactivities | Chimpanzee, Human, Monkey, Mouse, Rat |
Rabbit Polyclonal antibody to MX1 (myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse))
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 194 and 475 of MX1 (Uniprot ID#P20591) |
Active filters
Category
Applications
- IHC
Filter by
Target Symbol
- MAP2K1 (189)
- TP53 (160)
- MKI67 (146)
- NME1 (137)
- KRT19 (131)
- MSMB (123)
- OTC (119)
- ERBB2 (118)
- TG (118)
- LIPG (117)
- KLK8 (114)
- PECAM1 (114)
- NBN (110)
- PGR (110)
- MAP2K3 (101)
- CD4 (98)
- CTAG1B (97)
- CDKN2A (94)
- ABCB1 (92)
- CTNNB1 (88)
- AKT1 (86)
- PTPRC (84)
- CD99 (82)
- CHGA (82)
- ADIPOQ (81)
- PCNA (78)
- LGALS3 (77)
- APP (76)
- JUN (76)
- ERCC1 (75)
- EGFR (73)
- NKX3-1 (73)
- PIK3C2A (73)
- VSNL1 (73)
- BCL2 (71)
- TOP2A (70)
- KRT20 (69)
- MLANA (65)
- SENP2 (65)
- KIT (64)
- CD68 (62)
- KRT18 (62)
- NCAM1 (62)
- S100A9 (62)
- MS4A1 (60)
- BSG (59)
- CD44 (59)
- EPCAM (59)
- MEF2C (59)
- ESR1 (58)
- PDCD1 (58)
- CDH1 (57)
- AGR2 (56)
- MDM4 (56)
- PIK3CG (56)
- ABAT (55)
- BBOX1 (55)
- LOX (55)
- MUC1 (55)
- BTK (54)
- CD163 (54)
- KRT7 (54)
- MCM2 (54)
- MGLL (54)
- MTOR (54)
- RTRAF (54)
- TYMP (54)
- BUB1B (53)
- CTSL (53)
- F13A1 (53)
- MYC (53)
- PFKP (53)
- SQSTM1 (53)
- SYP (53)
- VBP1 (53)
- LTA4H (52)
- MGMT (52)
- NPR3 (52)
- PDE4A (52)
- POR (52)
- PPP5C (52)
- PROCR (52)
- UBE2G2 (52)
- AKR1A1 (51)
- CR2 (51)
- HSPD1 (51)
- PARVA (51)
- TYMS (51)
- CD8A (50)
- GBP2 (50)
- GFAP (50)
- KRT5 (50)
- LPIN1 (50)
- NR3C1 (50)
- PTPRE (50)
- VWF (50)
- AMACR (49)
- CD63 (49)
- NAPSA (49)
- RET (49)
Reactivities
- Human (53472)
- Mouse (34144)
- Rat (29127)
- Monkey (3229)
- Dog (2956)
- Bovine (641)
- Pig (370)
- Rabbit (229)
- Chicken (212)
- Hamster (197)
- Gorilla (179)
- Cow (168)
- Xenopus (165)
- Horse (145)
- Gibbon (141)
- Primate (129)
- Bat (118)
- Zebrafish (113)
- Rhesus Monkey (110)
- Chimpanzee (101)
- Canine (72)
- X. tropicalis (71)
- Porcine (68)
- Guinea Pig (49)
- Sheep (44)
- Orang-Utan (40)
- Feline (26)
- Other (Wide Range) (24)
- Mammalian (20)
- Drosophila (19)
- C. elegans (16)
- Equine (16)
- Goat (12)
- Macaque (11)
- Gerbil (7)
- Fish (6)
- Murine (6)
- Yeast (5)
- All Species (4)
- Cynomolgus (4)
- Opossum (4)
- Baboon (3)
- Ferret (3)
- Frog (3)
- Marmoset (3)
- SARS-CoV-2 (3)
- Avian (2)
- Broad (2)
- Dengue virus (2)
- Escherichia coli (2)
- Fusion proteins containing the Flag Tag (2)
- Plant (2)
- Quail (2)
- SARS-CoV (2)
- Virus (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- Amphibian (1)
- Beluga (1)
- Birds (1)
- Canis (1)
- Carp (1)
- Drosophila melanogaster (1)
- Fungi (1)
- Helicobacter pylori (1)
- Insect (1)
- Medaka fish (1)
- Mink (1)
- Pufferfish (1)
- Salmonella Typhimurium (1)
- Spinach (1)
- Squirrel (1)
- Staphylococcus aureus (1)
- Tadpole (1)
- Trichinella spiralis (1)
- Vertebrates (1)
- White Fly (1)
Antibody Hosts
Isotypes
- IgG (25205)
- IgG1 (21973)
- IgG2a (6399)
- IgG2b (5287)
- Ig (2374)
- IgG1, kappa (247)
- IgM (183)
- IgG3 (140)
- IgG, kappa (133)
- IgG2a, kappa (82)
- IgG2b, kappa (61)
- IgG2 (25)
- IgY (20)
- IgG3, kappa (12)
- IgG2c (10)
- IgM, kappa (9)
- IgG1, lambda (8)
- Fab fragment, kappa (4)
- cocktail (4)
- IgG2, kappa (2)
- IgG2a, lambda (2)
- IgG2b, lambda (2)
- F(ab)2, kappa (1)
- IgA (1)
- IgA, kappa (1)
- IgE (1)
- IgG fraction (1)
- IgG1/IgK (1)
- IgG12b (1)
- IgG4 (1)
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
- Unmodified (2395)
- Phospho-specific (472)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (37)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (7)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- Acetyl K12 (2)
- Acetyl K5 (2)
- Phospho S127 (2)
- Phospho S39 (2)
- Phospho S727 (2)
- Phospho S795 (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (2)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- TriMethyl K56 (2)
- Acetyl K15 (1)
- Acetyl K18 (1)
- Acetyl K23 (1)
- Acetyl K27 (1)
- Acetyl K56 (1)
- Acetyl K8 (1)
- Acetyl K9 (1)
- Acetyl K9/K14/K18/K23/K27 (1)
- Asymmetric DiMethyl R3 (1)
- DiMethyl K385 (1)
- MonoMethyl K36 (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Pan DiMethyl-lysine (1)
- Phospho S1 (1)
- Phospho S10 (1)
- Phospho S10/T11 (1)
- Phospho S104 (1)
- Phospho S1177 (1)
- Phospho S1248 (1)
- Phospho S15 (1)
- Phospho S157 (1)
- Phospho S182 (1)
- Phospho S240/244 (1)
- Phospho S243 (1)
- Phospho S280 (1)
- Phospho S33 (1)
- Phospho S33/S37/T41 (1)
- Phospho S37 (1)
- Phospho S376 (1)
- Phospho S425 (1)
- Phospho S428 (1)
- Phospho S455 (1)
- Phospho S465/467 + S423/425 (1)
- Phospho S473 (1)
- Phospho S473,Phospho S474,Phospho S472 (1)
- Phospho S5 (1)
- Phospho S51 (1)
- Phospho S529 (1)
- Phospho S612 (1)
- Phospho S62 (1)
- Phospho S73 (1)
- Phospho S80 (1)
- Phospho S82 (1)
- Phospho S89 (1)
- Phospho S957 (1)
- Phospho Ser416 (1)
- Phospho T11 (1)
- Phospho T17 (1)
- Phospho T179 (1)
- Phospho T18/S19 (1)
- Phospho T183/T172 (1)
- Phospho T1989 (1)
- Phospho T202/Y204 + T185/Y187 (1)
- Phospho T24,Phospho T32,Phospho T28 (1)
- Phospho T286 (1)
- Phospho T308 (1)
- Phospho T32 (1)
- Phospho T320 (1)
- Phospho T37/46 (1)
- Phospho T389 (1)
- Phospho T45 (1)
- Phospho T58 (1)
- Phospho T6 (1)
- Phospho T69/71 (1)
- Phospho T69/T71 (1)
- Phospho T70 (1)
- Phospho T91 (1)
- Phospho Y1007/1008 (1)
- Phospho Y1217 (1)
- Phospho Y1349 (1)
- Phospho Y15 (1)
- Phospho Y182 (1)
- Phospho Y207 (1)
- Phospho Y245 (1)
- Phospho Y412 (1)
- Phospho Y694 (1)
- Phospho Y705 (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- phospho T1079,Phospho T1041 (1)
Assay Types
Families
- Druggable Genome (27912)
- Transmembrane (10153)
- Transcription Factors (6487)
- Secreted Protein (4464)
- ES Cell Differentiation/IPS (3682)
- Protein Kinase (3218)
- Protease (2074)
- Stem cell - Pluripotency (2000)
- Adult stem cells (824)
- GPCR (774)
- Embryonic stem cells (524)
- Nuclear Hormone Receptor (513)
- Phosphatase (452)
- Cancer stem cells (406)
- Induced pluripotent stem cells (311)
- P450 (289)
- Stem cell relevant signaling - JAK/STAT signaling pathway (265)
- Stem cell relevant signaling - DSL/Notch pathway (222)
- Ion Channels: Other (221)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (139)
- Ion Channels: Potassium (101)
- Stem cell relevant signaling - Wnt Signaling pathway (100)
- Ion Channels: Transient receptor potential (93)
- Ion Channels: Cys-loop Receptors (59)
- Ion Channels: Glutamate Receptors (52)
- Ion Channels: Sodium (27)
- Ion Channels: Calcium (11)
- Ion Channels: Cyclic nucleotide gated (11)
- Ion Channels: ATP Receptors (10)
Pathways
- Metabolic pathways (4698)
- Pathways in cancer (3584)
- MAPK signaling pathway (2079)
- Focal adhesion (1952)
- Prostate cancer (1731)
- Neurotrophin signaling pathway (1473)
- Colorectal cancer (1445)
- T cell receptor signaling pathway (1412)
- ErbB signaling pathway (1382)
- Pancreatic cancer (1342)
- Toll-like receptor signaling pathway (1338)
- Regulation of actin cytoskeleton (1337)
- Chronic myeloid leukemia (1294)
- Melanoma (1279)
- Endometrial cancer (1239)
- Insulin signaling pathway (1233)
- Glioma (1202)
- Cell adhesion molecules (CAMs) (1184)
- Cytokine-cytokine receptor interaction (1172)
- Non-small cell lung cancer (1170)
- Bladder cancer (1138)
- Cell cycle (1133)
- Chemokine signaling pathway (1131)
- B cell receptor signaling pathway (1129)
- Progesterone-mediated oocyte maturation (1098)
- Apoptosis (1076)
- Acute myeloid leukemia (1064)
- Hematopoietic cell lineage (1012)
- Fc gamma R-mediated phagocytosis (1007)
- Fc epsilon RI signaling pathway (966)
- Wnt signaling pathway (961)
- Small cell lung cancer (960)
- Leukocyte transendothelial migration (946)
- Renal cell carcinoma (937)
- Jak-STAT signaling pathway (924)
- Endocytosis (914)
- Natural killer cell mediated cytotoxicity (872)
- Alzheimer's disease (866)
- GnRH signaling pathway (833)
- VEGF signaling pathway (822)
- p53 signaling pathway (796)
- Huntington's disease (781)
- Melanogenesis (779)
- Oocyte meiosis (751)
- Amyotrophic lateral sclerosis (ALS) (747)
- Neuroactive ligand-receptor interaction (735)
- Gap junction (731)
- Adherens junction (722)
- Calcium signaling pathway (721)
- Thyroid cancer (718)
- Adipocytokine signaling pathway (692)
- Purine metabolism (683)
- mTOR signaling pathway (648)
- Ubiquitin mediated proteolysis (581)
- Type II diabetes mellitus (579)
- Vascular smooth muscle contraction (570)
- Pyrimidine metabolism (568)
- Tight junction (536)
- Pathogenic Escherichia coli infection (533)
- Axon guidance (529)
- Epithelial cell signaling in Helicobacter pylori infection (520)
- Parkinson's disease (514)
- Long-term potentiation (513)
- Glycolysis / Gluconeogenesis (505)
- Long-term depression (505)
- Complement and coagulation cascades (495)
- Basal cell carcinoma (489)
- Primary immunodeficiency (479)
- Prion diseases (474)
- TGF-beta signaling pathway (451)
- Arginine and proline metabolism (449)
- Lysosome (446)
- Antigen processing and presentation (438)
- RIG-I-like receptor signaling pathway (434)
- Systemic lupus erythematosus (428)
- ECM-receptor interaction (407)
- NOD-like receptor signaling pathway (399)
- Dilated cardiomyopathy (381)
- Hypertrophic cardiomyopathy (HCM) (381)
- Valine (377)
- leucine and isoleucine degradation (370)
- PPAR signaling pathway (360)
- Drug metabolism - cytochrome P450 (354)
- Glycerolipid metabolism (350)
- Oxidative phosphorylation (350)
- Dorso-ventral axis formation (346)
- Metabolism of xenobiotics by cytochrome P450 (345)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (343)
- Phosphatidylinositol signaling system (339)
- Nucleotide excision repair (331)
- Cytosolic DNA-sensing pathway (327)
- Fatty acid metabolism (314)
- Viral myocarditis (313)
- Tryptophan metabolism (308)
- Autoimmune thyroid disease (305)
- Arachidonic acid metabolism (302)
- Spliceosome (271)
- Lysine degradation (270)
- Inositol phosphate metabolism (269)
- Type I diabetes mellitus (266)
- Alanine (265)
- aspartate and glutamate metabolism (265)
- Hedgehog signaling pathway (261)
- RNA degradation (257)
- Butanoate metabolism (254)
- DNA replication (253)
- Glutathione metabolism (250)
- Propanoate metabolism (250)
- Mismatch repair (245)
- Tyrosine metabolism (243)
- Retinol metabolism (236)
- Pyruvate metabolism (235)
- Base excision repair (233)
- Histidine metabolism (219)
- Notch signaling pathway (212)
- Glycine (207)
- serine and threonine metabolism (207)
- Allograft rejection (204)
- Cardiac muscle contraction (201)
- Renin-angiotensin system (197)
- ABC transporters (186)
- Vibrio cholerae infection (183)
- Homologous recombination (182)
- Proteasome (179)
- One carbon pool by folate (175)
- Starch and sucrose metabolism (173)
- Graft-versus-host disease (171)
- beta-Alanine metabolism (170)
- Cysteine and methionine metabolism (163)
- Pentose phosphate pathway (158)
- Drug metabolism - other enzymes (155)
- Amino sugar and nucleotide sugar metabolism (153)
- Fructose and mannose metabolism (148)
- Linoleic acid metabolism (141)
- Citrate cycle (TCA cycle) (138)
- Regulation of autophagy (136)
- Circadian rhythm - mammal (127)
- Maturity onset diabetes of the young (122)
- Nicotinate and nicotinamide metabolism (122)
- Sphingolipid metabolism (118)
- Terpenoid backbone biosynthesis (117)
- Galactose metabolism (114)
- Ribosome (114)
- Nitrogen metabolism (110)
- Glycerophospholipid metabolism (108)
- Primary bile acid biosynthesis (102)
- SNARE interactions in vesicular transport (101)
- Aminoacyl-tRNA biosynthesis (97)
- Folate biosynthesis (96)
- Asthma (95)
- Fatty acid elongation in mitochondria (94)
- Sulfur metabolism (92)
- N-Glycan biosynthesis (91)
- Caffeine metabolism (85)
- Porphyrin and chlorophyll metabolism (83)
- Non-homologous end-joining (81)
- Olfactory transduction (80)
- Phenylalanine metabolism (80)
- Taste transduction (78)
- Synthesis and degradation of ketone bodies (75)
- Androgen and estrogen metabolism (70)
- Selenoamino acid metabolism (70)
- Other glycan degradation (68)
- Methane metabolism (65)
- Glyoxylate and dicarboxylate metabolism (59)
- Biosynthesis of unsaturated fatty acids (57)
- RNA polymerase (56)
- Glycosaminoglycan degradation (51)
- Ascorbate and aldarate metabolism (44)
- Pantothenate and CoA biosynthesis (42)
- Basal transcription factors (41)
- Ether lipid metabolism (40)
- Limonene and pinene degradation (40)
- Cyanoamino acid metabolism (39)
- Riboflavin metabolism (38)
- Pentose and glucuronate interconversions (37)
- Taurine and hypotaurine metabolism (36)
- O-Glycan biosynthesis (34)
- Steroid biosynthesis (30)
- Fatty acid biosynthesis (29)
- C21-Steroid hormone metabolism (28)
- Vitamin B6 metabolism (25)
- Glycosphingolipid biosynthesis - ganglio series (23)
- Glycosphingolipid biosynthesis - lacto and neolacto series (21)
- D-Glutamine and D-glutamate metabolism (20)
- Keratan sulfate biosynthesis (18)
- Thiamine metabolism (17)
- leucine and isoleucine biosynthesis (17)
- Chondroitin sulfate biosynthesis (14)
- alpha-Linolenic acid metabolism (13)
- Glycosphingolipid biosynthesis - globo series (12)
- Heparan sulfate biosynthesis (11)
- Protein export (10)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (9)
- Phenylalanine (9)
- tyrosine and tryptophan biosynthesis (9)
- Lysine biosynthesis (6)
- Biotin metabolism (5)
- O-Mannosyl glycan biosynthesis (3)
- Ubiquinone and other terpenoid-quinone biosynthesis (3)